Celanese Corporation Reports Second Quarter 2021 Earnings; Raises Full Year Financial Outlook
Celanese Opens Pharmaceutical Drug Delivery Feasibility Lab at Florence, Kentucky Site
Celanese Corporation Announces New $1.0 Billion Share Repurchase Authorization
Celanese Corporation Declares Quarterly Dividend of $0.68 Per Share
Celanese to Hold Second Quarter Earnings Conference Call on July 23, 2021
Celanese to Acquire ExxonMobil’s Santoprene™ TPV Elastomers Business
Celanese Acquires POM Technology and Sales Agreements from Grupa Azoty
Celanese Corporation Reports First Quarter 2021 Earnings; Raises Full Year Financial Outlook
Celanese to Hold First Quarter Earnings Conference Call on April 23, 2021
